The NHS Confederation has been arguing for a so-called “mini deal” to be struck with the European Union – to help the flow of pharmaceuticals and other medical products even if no overarching agreement has been struck.
Earlier, I spoke to the Confederation’s International Director, Layla McCay, from Brussels. I started by asking her what she thought when she saw the contents of the Yellowhammer report.